Clinical Trial Update: Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Y-6 Sublingual Tablets for acute ischemic stroke is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Y-6 Sublingual Tablets

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke | Phase 3 | Status: NOT_YET_RECRUITING